Department of Otolaryngology, Taipei Medical University Hospital, Taipei, Taiwan.
PLoS One. 2013 Aug 15;8(8):e72097. doi: 10.1371/journal.pone.0072097. eCollection 2013.
This study attempted to reveal the incidence and risk of synchronous and metachronous esophageal cancer in subjects with oral, oropharyngeal and hypopharyngeal cancer based on a population-wide database in Taiwan.
We retrieved data for this cross-sectional study from the Taiwanese Longitudinal Health Insurance Database 2000. The study group included 2,965 subjects who had received their first-time diagnosis of oral/oropharyngeal/hypopharyngeal cancer in 2002∼2009. We assigned the date of their first diagnosis of oral/oropharyngeal/hypopharyngeal cancer as the index date. We also randomly retrieved 29,650 comparison subjects matched with the study subjects in terms of gender and age group. We assigned their first medical utilization that occurred in the index year as the index date for the comparison group. We further performed a conditional logistic regression to investigate the association between esophageal cancer and oral cancer.
Results showed that prevalences of esophageal cancer within 3 months before and after the index date were respectively 2.19% and 0.04% for the study and comparison groups. A conditional logistic regression revealed that the odds ratio (OR) of esophageal cancer for subjects with oral/oropharyngeal/hypopharyngeal cancer was 55.33 (95% confidence interval (CI): 29.86∼102.52) compared to comparison subjects. Furthermore, compared to comparison subjects, ORs for esophageal cancer were respectively 18.41 (95% CI: 8.50-39.85), 40.49 (95% CI: 15.11∼108.64), and 240.96 (95% CI: 125.49-462.69) for study subjects with a malignancy of the oral cavity, oropharynx, and hypopharynx.
We concluded that there were relatively high chances for synchronous and metachronous esophageal cancers being detected through panendoscopy in patients with oral, oropharyngeal, and hypopharyngeal cancers. The routine use of panendoscopy in such patients should be encouraged with a higher priority.
本研究试图基于台湾的一个全人群数据库,揭示口腔、口咽和下咽癌患者中同时性和异时性食管癌的发病率和风险。
我们从台湾 2000 年长期健康保险数据库中检索了这项横断面研究的数据。研究组包括 2965 名 2002 年至 2009 年间首次诊断为口腔/口咽/下咽癌的患者。我们将他们首次诊断口腔/口咽/下咽癌的日期定为索引日期。我们还随机选取了 29650 名与研究对象在性别和年龄组上相匹配的对照组。我们将他们在索引年内首次就诊的日期定为对照组的索引日期。我们进一步进行了条件逻辑回归分析,以探讨食管癌与口腔癌之间的关联。
结果显示,在研究组和对照组中,索引日期前 3 个月和后 3 个月食管癌的患病率分别为 2.19%和 0.04%。条件逻辑回归显示,与对照组相比,口腔/口咽/下咽癌患者发生食管癌的比值比(OR)为 55.33(95%置信区间(CI):29.86~102.52)。此外,与对照组相比,口腔癌、口咽癌和下咽癌患者的食管癌 OR 分别为 18.41(95% CI:8.50-39.85)、40.49(95% CI:15.11-108.64)和 240.96(95% CI:125.49-462.69)。
我们得出结论,在口腔、口咽和下咽癌患者中,通过全内镜检查发现同时性和异时性食管癌的几率相对较高。因此,应鼓励此类患者更优先地使用全内镜检查。